|4Nov 14, 6:04 AM ET

SPARKLE BYTE LTD 4

4 · CASI Pharmaceuticals, Inc. · Filed Nov 14, 2018

Insider Transaction Report

Form 4
Period: 2018-11-13
Transactions
  • Exercise of In-Money

    Warrant

    2018-11-13$0.13/sh750,771$93,8460 total
    Exercise: $1.69From: 2016-09-23Exp: 2019-09-23Common Stock (750,771 underlying)
  • Exercise of In-Money

    Common Stock

    2018-11-13$1.69/sh+1,699,753$2,872,58310,198,518 total
  • Exercise of In-Money

    Warrant

    2018-11-13$0.13/sh948,982$118,6230 total
    Exercise: $1.69From: 2016-04-15Exp: 2019-04-15Common Stock (948,982 underlying)
Footnotes (1)
  • [F1]These securities are directly owned by Sparkle Byte Limited ("Sparkle Byte") and may be deemed to be indirectly beneficially owned by the other reporting persons. Snow Moon Limited ("Snow Moon") holds 100% of the equity interest of Sparkle Byte. Tianjin Jingran Management Center (Limited Partnership) ("Tianjin Jingran") holds 100% of the equity interest of Snow Moon. He Xie Ai Qi is the general partner of Tianjin Jingran. Jianguang Li, Dongliang Lin and Hugo Shong are the directors of He Xie Ai Qi. Jianguang Li, Dongliang Lin and Fei Yang hold 12.5%, 43.75% and 43.75% of the equity interest of He Xie Ai Qi, respectively. The filing of this statement by the reporting persons shall not be deemed an admission that such persons are, for purposes of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this statement.

Documents

1 file
  • 4
    dp98329_4-sparkle.xmlPrimary